This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08656/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08656/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08656/identifier/pubchem-substance/
n13http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB08656/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08656/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08656
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08656 n13:DB08656
dcterms:title
5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide
adms:identifier
n8:99445127 n9:TTT n10:24941262 n11:24617535 n12:DB08656
n3:IUPAC-Name
n4:271B46F1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B46F7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B46F6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B46F3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B46F4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B46F5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B46EF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B46F0-363D-11E5-9242-09173F13E4C5 n4:271B46ED-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B46EE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B46FD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B46FE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B46F8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B46F9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B46FB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B46FA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B46FC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4703-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4705-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4706-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4702-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4701-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4704-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B46F2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B46FF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4700-363D-11E5-9242-09173F13E4C5